Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75)

References

• Aarthy, M., Panwar, U., Selvaraj, C., & Singh, S. K. (2017). Advantages of structure-based drug design approaches in neurological disorders, 15(8), 1136–1155. Current Neuropharmacology, doi:10.2174/1570159X15666170102145257
   PubMed Web of Science ®Google Scholar
• Adcock, S. A., & McCammon, J. A. (2006). Molecular dynamics: Survey of methods for simulating the activity of proteins. Chemical Reviews, 106(5), 1589–1615. doi:10.1021/cr040426m
   PubMed Web of Science ®Google Scholar
• Baell, J. B., Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. doi:10.1021/jm901137j
   PubMed Web of Science ®Google Scholar
• Bartholomeeusen, K., Christ, F., Hendrix, J., Rain, J. C., Emiliani, S., Benarous, R., … De Rijck, J. (2009). Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ. Journal of Biological Chemistry, 284(17), 11467–11477. doi:10.1074/jbc.M807781200 Epub 2009 Feb 25.
   PubMed Web of Science ®Google Scholar
• Bradley, C. M., & Craigie, R. (2005). Seeing is believing: Structure of the catalytic domain of HIV-1 integrase in complex with human LEDGF /P75 proc. Proceedings of the National Academy of Sciences, 102(49), 17543–17544. doi:10.1073/pnas.0509078102
   PubMed Web of Science ®Google Scholar
• Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., & Debyser, Z. (2005). The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. Journal of Biological Chemistry, 280, 17841–17847. doi:10.1074/jbc.M411681200
   PubMed Web of Science ®Google Scholar
• Cai, M., Zheng, R., Caffrey, M., Craigie, R., Clore, G. M., & Gronenborn, A. M. (1997). Solution structure of the N-terminal zinc-1 integrase. Nature Structural Biology, 4, 567–577. doi:10.1038/nsb0797-567
   PubMedGoogle Scholar
• Chen, J. C., Krucinski, J., Miercke, L. J., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000). Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding. Proceedings of the National Academy of Sciences, 97(15), 8233–8238. doi:10.1073/pnas.150220297
   PubMed Web of Science ®Google Scholar
• Cherepenov, P., Maertens, G. N., & Hare, S (2011). Structural insights into the retroviral DNA integration apparatus. Current Opinion in Structural Biology, 21, 249–256. doi:10.1016/j.sbi.2010.12.005
   PubMed Web of Science ®Google Scholar
• Chow, S. A., Vincent, K. A., Ellison, V., & Brown, P. O. (1992). Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science, 255(5045), 723–726. doi:10.1126/science.1738845
   PubMed Web of Science ®Google Scholar
• Christ, F., & Debyser, Z. (2013). The LEDGF/75 integrase interaction, a novel target for anti-HIV therapy. Virology, 435(1), 102–109. doi:10.1016/j.virol.2012.09.033
   PubMed Web of Science ®Google Scholar
• Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., … Debyser, Z. (2010). Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Nature Chemical Biology, 6(6), 442–448. doi:10.1038/nchembio.370
   PubMed Web of Science ®Google Scholar
• De Luca, L., Ferro, S., Gitto, R., Barreca, M. L., Agnello, S., Christ, F., … Chimirri, A. (2010). Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. Bioorganic & Medicinal Chemistry, 18(21), 7515–7521. doi:10.1016/j.bmc.2010.08.051
   PubMed Web of Science ®Google Scholar
• De Luca, L, Ferro, S., Morreale, F., De Grazia, S., & Chimirri, A. (2011). Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75. ChemMedChem, 6(7), 1184–1191. doi:10.1002/cmdc.201100071
   PubMed Web of Science ®Google Scholar
• De Luca, L., Morreale, F., & Chimirri, A. (2012). Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations. Journal of Chemical Information and Modeling, 52, 3245–3254. doi:10.1021/ci300361e
   PubMed Web of Science ®Google Scholar
• De Luca, L., Morreale, F., Christ, F., Debyser, Z., Ferro, S., & Gitto, R. (2013). New scaffolds of natural origin as IntegraseeLEDGF/p75 interaction inhibitors: Virtual screening and activity assays. European Journal of Medicinal Chemistry, 68, 405–411. doi:10.1016/j.ejmech.2013.07.025
   PubMed Web of Science ®Google Scholar
• Desmond. (2015). New York, NY: Schrodinger LLC.
   Google Scholar
• Du, L., Zhao, Y. X., Chen, J., Yang, L. M., Zheng, Y. T., Tang, Y., … Jiang, H. L. (2008). D77, one benzoic acid derivative, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75. Biochemical and Biophysical Research Communications, 375(1), 139–144. doi:10.1016/j.bbrc.2008.07.139
   PubMed Web of Science ®Google Scholar
• Durrant, J. D., & McCammon, J. A. (2011). Molecular dynamics simulation and drug discovery. BMC Biology, 9, 71. doi:10.1186/1741-7007-9-71
   PubMed Web of Science ®Google Scholar
• Eidahl, J. O., Crowe, B. L., North, J. A., McKee, C. J., Shkriabai, N., Feng, L., … Kvaratskhelia, M. (2013). Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes. Nucleic Acids Research, 41, 3924–3936. doi:10.1093/nar/gkt074
   PubMed Web of Science ®Google Scholar
• Engelman, A., & Cherepanov, P. (2008). The lentiviral integrase binding protein LEDGF/p75 and HIV-1 reaplication. PLoS Pathogens, 4, e1000046. doi:10.1371/journal.ppat.1000046
   PubMed Web of Science ®Google Scholar
• Engelman, A., & Craigie, R. (1992). Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. Journal of Virology, 66(11), 6361–6369.
   PubMed Web of Science ®Google Scholar
• FDA approves Raltegravir tablets. (2007). AIDS Patient Care STDS, 21, 889.
   Google Scholar
• Ferris, A. L., Wu, X., Hughes, C. M., Stewart, C., Smith, S. J., Milne, T. A., … Hughes, S. H. (2010). Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proceedings of the National Academy of Sciences, 107, 3135–3140. doi:10.1073/pnas.0914142107
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Shenkin, P. S. (2004). Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. doi:10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• GLIDE. (2015). New York, NY: Schrodinger, LLC.
   Google Scholar
• Goodarzi, G., Im, G. J., Brackmann, K., & Grandgenett, D. (1995). Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase. Journal of Virology, 69(10), 6090–6097.
   PubMed Web of Science ®Google Scholar
• Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010a). Retro viral intasome assemble and inhibition DNA strand transfer. Nature, 464(7286), 232–236. doi:10.1038/nature08784
   PubMed Web of Science ®Google Scholar
• Jaguar. (2015).New York, NY: Schrodinger, LLC.
   Google Scholar
• Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. doi:10.1021/ja9621760
   Web of Science ®Google Scholar
• Kaltama, C., & Murphy, R. (2012). Dolutegravir for the treatment of HIV. Expert Opinion on Investigational Drugs, 21(4), 523–530. doi:10.1517/13543784.2012.661713
   PubMed Web of Science ®Google Scholar
• Karplus, M. & Kuriyan, J. (2005). Molecular dynamics and protein function. Proceedings of the National Academy of Sciences of the United States of America, 102(19), 6679–6685. doi:10.1073/pnas.0408930102.
   PubMed Web of Science ®Google Scholar
• Lamb, M. L, & Saeh, J. C. (2006). Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. Journal of Medicinal Chemistry, 49(16), 4805–4808.
   Google Scholar
• LigPrep. (2015). New York, NY: Schrodinger LLC.
   Google Scholar
• Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., … Poeschla, E. M. (2006). An essential role for LEDGF/p75 in HIV integration. Science, 314(5798), 461–464. doi:10.1126/science.1132319
   PubMed Web of Science ®Google Scholar
• Luo, Y., & Muesing, M. A. (2010). Prospective strategies for targeting HIV-1 integrase function. Future Medicinal Chemistry, 2(7), 1055–1060. doi:10.4155/fmc.10.205
   PubMed Web of Science ®Google Scholar
• Lyne, P. D., Lamb, M. L., & Saeh, J. C. (2006). Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. Journal of Medicinal Chemistry, 49(16), 4805–4808. doi:10.1021/jm060522a.
   PubMed Web of Science ®Google Scholar
• Maigan, S., Guilloteau, J. P., Zhou-Lii, Q., Clement Mella, C., & Mikol, V. (1998). Crystal structures of the catalytic domain of HIV-1 IN free and comlexed with its metal cofactor: High level of similarity of the active site with other viral integrases. Journal of Molecular Biology, 282, 359–368. doi: v10.1006/jmbi.1998.2002
   PubMed Web of Science ®Google Scholar
• Malet, I., Delelis, O., Valantin, M. A., Montes, B., Soulie, C., Wirden, M., ... Marcelin, A. G. (2008). Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro. Antimicrobial Agents and Chemotherapy, 52(4), 1351–1358. doi:10.1128/AAC.01228-07. Epub 2008 Jan 28.
   PubMed Web of Science ®Google Scholar
• McColl, D. J., & Chen, X. (2010). Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy. Antiviral Research, 85(1), 101–118. doi:10.1016/j.antiviral.2009.11.004
   PubMed Web of Science ®Google Scholar
• Pommier, Y., Johnson, A. A., & Marchand, C. (2005). Integrase inhibitors to treat HIV/Aids. Nature Reviews Drug Discovery, 4(3), 236–248. doi:10.1038/nrd1660
   PubMed Web of Science ®Google Scholar
• Prime. (2015). New York, NY: Schrodinger LLC.
   Google Scholar
• Protein Preparation Wizard. (2015). New York, NY: Schrodinger LLC.
   Google Scholar
• Qikprop. (2015). New York, NY: Schrodinger LLC.
   Google Scholar
• Reddy, K. K., Singh, S. K., Tripathi, S. K., Selvaraj, C., & Suryanarayanan, V. (2013). Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14α-demethylase inhibitors. Journal of Receptors and Signal Transduction, 33(4), 234–243. doi:10.3109/10799893.2013.789912
   PubMed Web of Science ®Google Scholar
• Reddy, K. K., Singh, P., & Singh, S. K. (2014). Blocking the interaction between HIV-1 integrase and Human LEDGF/p75: Mutational studies, virtual screening and molecular dynamics. Molecular BioSystems, 10, 526–536. doi:10.1039/C3MB70418A
   PubMed Web of Science ®Google Scholar
• Selvaraj, C., Priya, R. B., Lee, J. K., & Singh, S. K. (2015). Mechanistic insights of SrtA-LPXTG blockers targeting the transpeptidase mechanism in Streptococcus mutans. RSC Advances, 5(122), 100498–100510, doi:10.1039/C5RA12869B
   Web of Science ®Google Scholar
• Sherman, W., Beard, H. S., & Farid, R. (2004). Use of an induced fit receptor structure in virtual screening. Journal of Medicinal Chemistry, 47, 1739–1749. doi:10.1111/j.1747-0285.2005.00327.x
   PubMed Web of Science ®Google Scholar
• Singh, S., Prabhu, S. V., Suryanarayanan, V., Bhardwaj, R., Singh, S. K., & Dubey, V. K. (2016). Molecular docking and structure based virtual screening studies of potential drug target, CAAX prenyl proteases, of Leishmania donovani. Journal of Biomolecular Structure & Dynamics, 34(11), 2367–2386. doi:10.1080/07391102.2015.1116411
   PubMed Web of Science ®Google Scholar
• Suryanarayanan, V., & Singh, S. K. (2015). Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach. Journal of Receptors and Signal Transduction, 35(5), 370–380. doi:10.3109/10799893.2014.956756
   PubMed Web of Science ®Google Scholar
• Toledo Warshaviak, D., Golan, G., Borrelli, K. W., Zhu, K., & Kalid, O., (2014). Structure-based virtual screening approach for discovery of covalently bound ligands. Journal of Chemical Information and Modeling, 54, 1941–1950. doi:10.1021/ci500175r
   PubMed Web of Science ®Google Scholar
• Truchon, J.-F., & Bayly, C. I. (2007). Evaluating virtual screening methods: good and bad metrics for the ‘early recognition’ problem. Journal of Chemical Information and Modeling, 47, 488–508. doi:10.1021/ci600426e
   PubMed Web of Science ®Google Scholar
• Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W, … Sakowicz, R. New class of HIV-1 integrase (IN) inhibitors with a dual mode of action. Journal of Biological Chemistry, 287(25), 21189–21203. doi: 10.1074/jbc.M112.347534
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2016). Global AIDS. Update 2016, Geneva.
   Google Scholar
• Zheng, R., Jenkins, T. M., & Craigie, R. (1996). Zinc folds the N – terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proceedings of the National Academy of Sciences, 93, 13659–13664.10.1073/pnas.93.24.13659
   PubMed Web of Science ®Google Scholar